Patent · US Active

Nanoparticulate carverdilol formulations

US8367112B2 · kind B2 · utility

2Cited by

88References

22Claims

0Family size

Assignee

Alkermes Pharma Ireland Limited · IE

Inventors

Gary Liversidge · West Chester, US
Scott Jenkins · San Francisco, US

Key dates

Filing date	Feb 28, 2006
Grant date	Feb 5, 2013
Priority date	—
Expiry date	Jul 22, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention is directed to nanoparticulate carvedilol compositions having improved pharmacokinetic profiles, improved bioavailability, dissolution rates and efficacy. In one embodiment, the nanoparticulate carvedilol composition has an effective average particle size of less than about 2000 nm.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.